Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis
NCT: NCT05330611 · COMPLETED
Brief Summary
The purpose of this research study is to examine the effectiveness of using the Iovera Smart Time 190, for ultrasound-guided cryoneurolysis, in trauma patients 18-64 years old with rib fractures that are not candidates for surgical stabilization. This will offer patients the benefits of cryoneurolysis of the intercostal nerves, thereby providing short and long term pain control while their ribs heal. The Iovera Smart Tip 190 is FDA approved for cryoneurolysis.
Frequently Asked Questions
What is Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis?
Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis is a clinical trial registered under NCT05330611. Current status: COMPLETED.
What is the status of NCT05330611?
The current status of NCT05330611 (Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis) is: COMPLETED.
When did Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis start?
Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis started on 2023-02-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.